Alexandria Real Estate Equities Inc. (0HCH)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 42.83 |
|---|---|
| 52-week range | 39.45 – 80.80 |
| Return, 1 month / 3 months | −18.4% / −12.1% |
| Return, 1 year / 3 years | −41.2% / −46.9% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 46.8% |
| Worst drawdown (1 year) | -45.9% |
| Average daily value traded | 0.09M USD |
| Dividend yield | 6.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alexandria Real Estate Equities is a real estate investment trust that owns and operates laboratory and office space for the life science and technology industries. Its campuses are clustered in innovation hubs across the United States, where it leases space to pharmaceutical companies, biotechnology firms, research institutions and technology tenants. The company is based in Pasadena, California, and develops and manages collaborative campuses designed for scientific research and development.
On this site Alexandria Real Estate Equities Inc. appears as a stock on the London Exchange (UK), code 0HCH, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alexandria Real Estate Equities Inc. (0HCH) trades on the London Exchange in UK. It last closed at USD 42.83 on 23 October 2026.
Its price-based Market X-Ray is 33 out of 100 (a weak price profile), ranking 2,939 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 41.2% and over the last three months it fell 12.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.1% | ||
| From 52-week high | -44.9% | ||
| Momentum | 26 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.1% | ||
| 6-month return | -3.5% | ||
| 12-month return, skipping the last month | -28.0% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 46.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.9% | ||
| Liquidity | 29 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 86 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.7% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.9% |
|---|---|
| 1 month | −18.4% |
| 3 months | −12.1% |
| 6 months | −3.5% |
| 1 year | −41.2% |
| 3 years | −46.9% |
| 5 years | −74.1% |
Signals
| 50-day / 200-day average | 48.38 / 48.73 |
|---|---|
| Golden / death cross (60 days) | Death, 4 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.96 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2026 | USD 0.7200 |
| 30 Jun 2026 | USD 0.7200 |
| 31 Mar 2026 | USD 0.7200 |
| 30 Dec 2025 | USD 0.7200 |
| 30 Sep 2025 | USD 1.3200 |
| 30 Jun 2025 | USD 1.3200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.